Yoichiro Yoshida Selected Research

XELOX

6/2015	Can grade 2 neutropenia predict the risk of grade 3 neutropenia in metastatic colorectal cancer patients treated with chemotherapy?
4/2015	Administration of chemotherapy via the median cubital vein without implantable central venous access ports: port-free chemotherapy for metastatic colorectal cancer patients.
1/2015	A single-arm Phase II validation study of preventing oxaliplatin-induced hypersensitivity reactions by dexamethasone: the AVOID trial.
5/2014	A Report of Disseminated Carcinomatosis of the Bone Marrow Originating from Transverse Colon Cancer Successfully Treated with Chemotherapy Using XELOX plus Bevacizumab.
1/2014	Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer.
1/2013	A Successfully Resected Case of Recurrent Lung and Liver Metastases of Rectal Cancer Treated with XELIRI + Bevacizumab Therapy.
5/2012	Early start of chemotherapy after resection of brain metastasis from colon cancer with synchronous multiple liver metastases.
5/2011	Early start of chemotherapy after resection of primary colon cancer with synchronous multiple liver metastases: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoichiro Yoshida Research Topics

Disease

31	Colorectal Neoplasms (Colorectal Cancer) 08/2022 - 03/2011
22	Neoplasms (Cancer) 06/2022 - 03/2002
10	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2003
4	Peripheral Nervous System Diseases (PNS Diseases) 11/2020 - 01/2015
4	Pain (Aches) 08/2020 - 04/2015
4	Neutropenia 01/2019 - 06/2015
3	Colonic Neoplasms (Colon Cancer) 01/2021 - 05/2011
3	Rectal Neoplasms (Rectal Cancer) 10/2020 - 01/2013
2	Myositis (Idiopathic Inflammatory Myopathies) 06/2022 - 01/2017
2	Infections 05/2021 - 11/2016
2	Hypersensitivity (Allergy) 05/2021 - 01/2015
2	Sigmoid Neoplasms 02/2021 - 01/2021
2	Thrombosis (Thrombus) 02/2021 - 09/2020
2	Surgical Wound Infection 11/2016 - 04/2013
2	Wounds and Injuries (Trauma) 11/2016 - 04/2013
1	Liver Diseases (Liver Disease) 08/2022
1	Fatigue 08/2022
1	Dermatomyositis (Dermatopolymyositis) 06/2022
1	Disease Progression 01/2022
1	Atopic Dermatitis (Atopic Eczema) 05/2021
1	Job Syndrome (Hyper-IgE Syndrome) 05/2021
1	Eczema 05/2021
1	Bacterial Infections (Bacterial Infection) 05/2021
1	Skin Manifestations 05/2021
1	Pneumoperitoneum 01/2021
1	Embolism (Embolus) 01/2021
1	Paresthesia (Dysesthesia) 11/2020
1	Inflammation (Inflammations) 10/2020
1	Venous Thromboembolism 09/2020
1	Hemorrhage 09/2020
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2020
1	Thromboembolism 09/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 09/2020
1	Hypesthesia (Numbness) 08/2020
1	Myalgia 01/2017
1	Dyspnea (Shortness of Breath) 01/2017
1	Dihydropyrimidine Dehydrogenase Deficiency 09/2015
1	Disseminated Intravascular Coagulation 05/2014

Drug/Important Bio-Agent (IBA)

13	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2020 - 03/2011
9	Bevacizumab (Avastin)FDA Link 06/2021 - 01/2013
8	XELOXIBA 06/2015 - 05/2011
6	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 03/2011
6	Capecitabine (Xeloda)FDA Link 01/2020 - 05/2011
5	trifluridine tipiracil drug combinationIBA 06/2021 - 01/2017
5	Leucovorin (Folinic Acid)FDA Link 01/2013 - 03/2011
4	Pharmaceutical PreparationsIBA 12/2019 - 03/2002
4	Irinotecan (Camptosar)FDA LinkGeneric 04/2019 - 05/2011
2	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2019
2	Triclosan (pHisoHex)FDA Link 11/2016 - 04/2013
2	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 01/2005
2	mitochondrial transcription factor AIBA 08/2015 - 03/2011
1	regorafenibIBA 08/2022
1	AutoantibodiesIBA 06/2022
1	InterleukinsIBA 06/2022
1	LigandsIBA 06/2022
1	CytokinesIBA 06/2022
1	ChemokinesIBA 06/2022
1	Interleukin-18 (Interleukin 18)IBA 06/2022
1	Circulating Tumor DNAIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Immunoglobulin E (IgE)IBA 05/2021
1	Carbon DioxideIBA 01/2021
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2020
1	InflammasomesIBA 10/2020
1	tetrapropylammonium perruthenateIBA 10/2020
1	Duloxetine Hydrochloride (Cymbalta)FDA Link 08/2020
1	5-nitrouracilIBA 01/2020
1	Carcinoembryonic AntigenIBA 04/2019
1	IsoenzymesIBA 04/2019
1	Panitumumab (Vectibix)FDA Link 04/2019
1	lactate dehydrogenase 1 (LDH1)IBA 04/2019
1	lactate dehydrogenase 4IBA 04/2019
1	Prednisolone (Predate)FDA LinkGeneric 01/2017
1	SteroidsIBA 01/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Asu(1,6)- argipressin (VAS-A)IBA 01/2016
1	PlatinumIBA 08/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2015
1	SolutionsIBA 01/2015
1	Denosumab FDA Link 05/2014

Therapy/Procedure

23	Drug Therapy (Chemotherapy) 01/2022 - 03/2002
12	Therapeutics 08/2022 - 08/2011
3	Colectomy 01/2021 - 05/2011
3	Combination Drug Therapy (Combination Chemotherapy) 01/2013 - 05/2011
2	Perioperative Period 01/2022 - 01/2021
2	Sutures (Suture) 11/2016 - 04/2013
2	Intravenous Infusions 01/2016 - 04/2015
1	Precision Medicine 01/2022
1	Catheters 02/2021
1	Adjuvant Chemotherapy 02/2021
1	Ligation 01/2021
1	Pelvic Exenteration 01/2021
1	Islets of Langerhans Transplantation 10/2020
1	Proctectomy 10/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2020
1	Hepatectomy 01/2017
1	Operative Surgical Procedures 11/2016
1	Punctures 04/2015